Self-efficacy Enhancement in a Virtual Reality Training for Fear of Heights
Self-efficacy Enhancement in a Virtual Reality Training for Fear of Heights: Promoting Mastery Experiences
Ruhr University of Bochum
60 participants
Jun 22, 2023
INTERVENTIONAL
Conditions
Summary
Self-efficacy (SE) enhancement after virtual reality exposure (VRET) for heights can promote treatment-induced effects (Raeder et al. 2019). Raeder et al (2019) employed an intervention to enhance SE by introducing specific questions about autobiographical events of success and mastery experiences in the course of VRET. Building on these previous findings, the present study aims to examine whether SE-enhancement DURING and/or AFTER a brief VR-based exposure for fear of heights (in the following referred to as VR-height-exposure) is suitable to promote exposure-induced reductions in height-related fear and avoidance. To this end, repeated visual feedback DURING a brief VR-height-exposure will be used to selectively promote SE and mastery experiences. In a similar vein, SE-enhancement AFTER VR-height-exposure will be administered. The effects of these interventions will be assessed on different treatment outcome levels. It will be further examined whether the combined SE enhancement (DURING and AFTER exposure) is more effective that 1.) SE enhancement performed DURING VR-height-exposure only or 2.) SE enhancement performed AFTER VR-height-exposure only. The investigators hypothesize that SE enhancement (either administered DURING or AFTER VR-height-exposure) will be more effective (as indicated by more pronounced reductions in height-related fear and avoidance) than VR-height-exposure alone. It is further expected that the combined SE enhancement DURING and AFTER VR-height-exposure will be more effective compared to SE enhancement DURING VR-height-exposure alone and/or SE enhancement DURING VR-height-exposure alone.
Eligibility
Inclusion Criteria3
- age 18 to 65 years
- fear of heights
- normal or corrected vision
Exclusion Criteria7
- acute psychotherapy or psychotherapy in the past 2 years
- acute psychiatric drug intake
- acute schizophrenic or psychotic symptoms
- acute major depressive episode with severe symptoms
- acute substance use disorder
- neurological disorder or mental disability
- cardiac arrhythmias or pacemaker
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Visual progress feedback and words of positive affirmation will be presented triggered by checkpoints set in the VR-height-exposure.
specific instructions regarding the retrieval of mastery experiences during exposure will be given (modified version of the procedure used in Raeder et al. 2019).
specific instructions regarding the retrieval of the exposure session will be given without an emphasis on personal mastery experience (modified version of the procedure used in Raeder et al. 2019).
Participants can not trigger any checkpoints during VR and therefore not receive any progress feedback or positive affirmation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05824884